Claire Mignard
Rouen, 76000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Persistence of anti-Desmoglein 3 Antibodies in Patients with Pemphigus Vulgaris in Clinical Remission is Associated with Restricted Isotype Diversity and Desmoglein 3 Ectodomain Recognition.
Journal: The British journal of dermatology
Published: October 23, 2025
Pellagra in anorexia nervosa.
Journal: Annales de dermatologie et de venereologie
Published: July 14, 2025
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
Journal: JAMA dermatology
Published: January 24, 2024
Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).
Journal: The oncologist
Published: December 17, 2023
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns.
Journal: Annales de dermatologie et de venereologie
Published: February 07, 2023
Pustular Lichenoid Eruptions Induced by Immune Checkpoint Inhibitors: Two Case Reports and a Review of the Literature.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: August 28, 2022
Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus.
Journal: The Journal of investigative dermatology
Published: October 26, 2020
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
Journal: JAMA dermatology
Published: March 19, 2020
Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial.
Journal: The British journal of dermatology
Published: September 24, 2019
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma.
Journal: Journal of oncology
Published: June 29, 2018
Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib.
Journal: JAAD case reports
Published: January 04, 2018
Syphilitic osteitis in an HIV-negative patient
Journal: Annales de dermatologie et de venereologie
Published: May 17, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026